Cargando…

Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease

Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusan, Simon, Surat, Güzin, Kelm, Matthias, Anger, Friedrich, Kim, Mia, Germer, Christoph-Thomas, Schlegel, Nicolas, Flemming, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330589/
https://www.ncbi.nlm.nih.gov/pubmed/35893433
http://dx.doi.org/10.3390/jcm11154343
_version_ 1784758198637428736
author Kusan, Simon
Surat, Güzin
Kelm, Matthias
Anger, Friedrich
Kim, Mia
Germer, Christoph-Thomas
Schlegel, Nicolas
Flemming, Sven
author_facet Kusan, Simon
Surat, Güzin
Kelm, Matthias
Anger, Friedrich
Kim, Mia
Germer, Christoph-Thomas
Schlegel, Nicolas
Flemming, Sven
author_sort Kusan, Simon
collection PubMed
description Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectrum in penetrating ileitis is sparse. We retrospectively assessed outcomes of 46 patients with terminal penetrating Ileitis where microbial diagnostics have been performed and compared microbial spectrum and antibiotic resistance profile of CD patients with patients suffering from diverticulitis with intraabdominal abscess formation. In both groups, the most frequently isolated pathogen was the gram-negative bacterium E. coli belonging to the family of Enterobacterales. However, overall Enterobacterales were significantly more often verifiable in the control group than in CD patients. Furthermore, microbial analysis showed significant differences regarding isolation of anaerobic pathogens with decreased frequency in patients with CD. Subgroup analysis of CD patients to evaluate a potential influence of immunosuppressive therapy on microbial spectrum only revealed that Enterobacterales was less frequently detected in patients treated with steroids. Immunosuppressive therapy did not show any impact on all other groups of pathogens and did not change antibiotic resistance profile of CD patients. In conclusion, we were able to demonstrate that the microbial spectrum of CD patients does differ only for some pathogen species without increased rate of antibiotic resistance. However, the empiric antibiotic therapy for CD-associated intra-abdominal abscess remains challenging since different points such as local epidemiological and microbiological data, individual patient risk factors, severity of infection, and therapy algorithm including non-surgical and surgical therapy options should be considered before therapeutical decisions are made.
format Online
Article
Text
id pubmed-9330589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93305892022-07-29 Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease Kusan, Simon Surat, Güzin Kelm, Matthias Anger, Friedrich Kim, Mia Germer, Christoph-Thomas Schlegel, Nicolas Flemming, Sven J Clin Med Article Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectrum in penetrating ileitis is sparse. We retrospectively assessed outcomes of 46 patients with terminal penetrating Ileitis where microbial diagnostics have been performed and compared microbial spectrum and antibiotic resistance profile of CD patients with patients suffering from diverticulitis with intraabdominal abscess formation. In both groups, the most frequently isolated pathogen was the gram-negative bacterium E. coli belonging to the family of Enterobacterales. However, overall Enterobacterales were significantly more often verifiable in the control group than in CD patients. Furthermore, microbial analysis showed significant differences regarding isolation of anaerobic pathogens with decreased frequency in patients with CD. Subgroup analysis of CD patients to evaluate a potential influence of immunosuppressive therapy on microbial spectrum only revealed that Enterobacterales was less frequently detected in patients treated with steroids. Immunosuppressive therapy did not show any impact on all other groups of pathogens and did not change antibiotic resistance profile of CD patients. In conclusion, we were able to demonstrate that the microbial spectrum of CD patients does differ only for some pathogen species without increased rate of antibiotic resistance. However, the empiric antibiotic therapy for CD-associated intra-abdominal abscess remains challenging since different points such as local epidemiological and microbiological data, individual patient risk factors, severity of infection, and therapy algorithm including non-surgical and surgical therapy options should be considered before therapeutical decisions are made. MDPI 2022-07-26 /pmc/articles/PMC9330589/ /pubmed/35893433 http://dx.doi.org/10.3390/jcm11154343 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kusan, Simon
Surat, Güzin
Kelm, Matthias
Anger, Friedrich
Kim, Mia
Germer, Christoph-Thomas
Schlegel, Nicolas
Flemming, Sven
Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title_full Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title_fullStr Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title_full_unstemmed Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title_short Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
title_sort microbial spectrum and antibiotic resistance in patients suffering from penetrating crohn’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330589/
https://www.ncbi.nlm.nih.gov/pubmed/35893433
http://dx.doi.org/10.3390/jcm11154343
work_keys_str_mv AT kusansimon microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT suratguzin microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT kelmmatthias microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT angerfriedrich microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT kimmia microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT germerchristophthomas microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT schlegelnicolas microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease
AT flemmingsven microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease